15 results
S-3
EX-1.2
COGT
Cogent Biosciences Inc
2 Apr 19
Shelf registration
12:00am
or candidate for political office) in order to influence official action, or to any person in violation of any applicable anti-corruption laws; and the Company … , the Subsidiary and their respective affiliates have conducted their businesses in compliance with applicable anti-corruption laws and have instituted
8-K
EX-1.1
COGT
Cogent Biosciences Inc
2 Dec 20
Entry into a Material Definitive Agreement
5:08pm
, or to any person in violation of any applicable anti-corruption laws; and the Company, its subsidiaries and their respective affiliates have conducted … their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies
8-K
EX-1.1
COGT
Cogent Biosciences Inc
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm
action, or to any person in violation of any applicable anti-corruption laws; and the Company, its subsidiaries and their respective affiliates have … conducted their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies
8-K
EX-1.1
COGT
Cogent Biosciences Inc
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
official action, or to any person in violation of any applicable anti-corruption laws; and the Company, its subsidiaries and their respective affiliates … have conducted their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain
8-K/A
EX-1.1
COGT
Cogent Biosciences Inc
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
action, or to any person in violation of any applicable anti-corruption laws; and the Company, its subsidiaries and their respective affiliates have … conducted their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies
8-K
EX-10.1
gn9rkiyuqn3fix6 rq7j
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-10.1
34uwucwgnj0fnv43t6d
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-10.1
n13wug0w
9 Jul 21
Entry into a Material Definitive Agreement
4:01pm
424B5
fj6new zwe5
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
b3hhpwco8n71rkgt7tl
30 Nov 20
Prospectus supplement for primary offering
5:28pm
- Prev
- 1
- Next